Clinical Trial Update: Prevention and Treatment of Hemodialysis Vascular Access Malfunction [Phase 2]

View source ↗

Summary

The Phase 2 clinical trial on prevention and treatment of hemodialysis vascular access malfunction was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Vanderbilt University | Conditions: End-Stage Renal Disease | Phase 2 | Status: WITHDRAWN